Home > Healthcare > Medical Devices > Therapeutic Devices > Tubeless Insulin Pump Market

Tubeless Insulin Pump Market Share

Report ID: GMI2032
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Tubeless Insulin Pump Market Share

The tubeless insulin pump industry is consolidated in nature, with major companies competing to offer superior tubeless insulin pumps in this business space. Prominent players such as Insulet Corporation hold a significant company market share. These companies are diligently directing their efforts towards continuous product innovation to gain substantial market share. For instance, Insulet Corporation announced the U.S. FDA approval of the Omnipod DASH Insulin Management System with a tubeless pump, bluetooth connectivity, and personal diabetes manager. This enables quick access to insulin therapy information to patients as well as professionals on their smartphones.

Some of the major market players operating in the tubeless insulin pump industry are:

Insulet Corporation
Roche
Medtrum Technologies
Terumo Corporation
Mannkind Corporation
Terumo Corporation

Major market players are adopting strategic formulations such as forward integration, new product development, geographical expansion, and research collaborations to garner maximum industry share and promote company expansion.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The tubeless insulin pump industry was valued at around USD 1.6 billion in 2022 and is projected to reach over USD 8.9 billion by the end of 2032, owing to the increasing prevalence of diabetes.

The homecare segment accounted for USD 1.2 billion in 2022 and is set to witness notable growth in the coming years, attributed to the surging adoption of tubeless insulin pumps in home care settings as well as user-friendly and easy-to-use nature of these devices.

North America market was worth USD 974 million in 2022 and is projected to reach USD 5.5 billion by 2032, pertaining to the facilitative reimbursement scenario, the high prevalence of diabetes, and the presence of major players in the region.

Insulet Corporation, Roche, Medtrum Technologies, Terumo Corporation, Mannkind Corporation, and Terumo Corporation, among others.